OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
600309$77.5858

Wanhua Chemical Group Co Ltd

Commodity ChemicalsVerified

Wanhua Chemical Group maintains a capital structure with a debt-to-equity ratio of 1.33, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.63, suggesting potential short-term liquidity constraints. The price-to-book ratio of 2.65 and price-to-tangible-book ratio of 2.65 indicate that the market values the company at a premium to its book value. Profitability metrics show a return on equity (ROE) of 4.39% and a return on assets (ROA) of 1.37%, both below the typical thresholds for high-performing chemical firms. The company's gross profit margin is 14.84% (7.55 billion CNY gross profit on 50.91 billion CNY revenue), and its operating margin is 10.22% (5.20 billion CNY operating income on 50.91 billion CNY revenue), which are in line with industry norms for commodity chemicals. Wanhua's revenue is concentrated in its core polyurethane and other chemical products, with no disclosed geographic revenue breakdown in the latest financials. The company's exposure to regional markets is not specified, but its global operations suggest potential diversification benefits. The company's growth trajectory is mixed. While it reported a revenue of 50.91 billion CNY in the latest period, the outlook for the current fiscal year is not explicitly provided. The price targets from analysts range from 53.00 CNY to 126.00 CNY, with a mean of 98.52 CNY and a median of 105.00 CNY, indicating a generally positive sentiment. Risk factors include a negative net cash position after subtracting total debt, which could impact the company's ability to meet short-term obligations. The dilution risk is assessed as low, with no significant dilution potential in the basic shares outstanding. The company's capital expenditures of -20.07 billion CNY suggest a net outflow, potentially indicating investment in long-term projects or asset retirements. Recent events include analyst price targets and recommendations, with a mean recommendation of 1.81 (1=strong buy, 5=strong sell) and a strong-buy count of 7. These signals suggest a generally favorable view from the investment community.

30-day price · 600309+2.36 (+3.0%)
Low$79.22High$93.14Close$81.81As of17 May, 00:00 UTC
Profile
CompanyWanhua Chemical Group Co Ltd
Ticker600309.SS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Wanhua Chemical Group Co Ltd is a leading global manufacturer and supplier of polyurethane raw materials, operating in the commodity chemicals industry.

Classification. Wanhua is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Wanhua Chemical Group maintains a capital structure with a debt-to-equity ratio of 1.33, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.63, suggesting potential short-term liquidity constraints. The price-to-book ratio of 2.65 and price-to-tangible-book ratio of 2.65 indicate that the market values the company at a premium to its book value. Profitability metrics show a return on equity (ROE) of 4.39% and a return on assets (ROA) of 1.37%, both below the typical thresholds for high-performing chemical firms. The company's gross profit margin is 14.84% (7.55 billion CNY gross profit on 50.91 billion CNY revenue), and its operating margin is 10.22% (5.20 billion CNY operating income on 50.91 billion CNY revenue), which are in line with industry norms for commodity chemicals. Wanhua's revenue is concentrated in its core polyurethane and other chemical products, with no disclosed geographic revenue breakdown in the latest financials. The company's exposure to regional markets is not specified, but its global operations suggest potential diversification benefits. The company's growth trajectory is mixed. While it reported a revenue of 50.91 billion CNY in the latest period, the outlook for the current fiscal year is not explicitly provided. The price targets from analysts range from 53.00 CNY to 126.00 CNY, with a mean of 98.52 CNY and a median of 105.00 CNY, indicating a generally positive sentiment. Risk factors include a negative net cash position after subtracting total debt, which could impact the company's ability to meet short-term obligations. The dilution risk is assessed as low, with no significant dilution potential in the basic shares outstanding. The company's capital expenditures of -20.07 billion CNY suggest a net outflow, potentially indicating investment in long-term projects or asset retirements. Recent events include analyst price targets and recommendations, with a mean recommendation of 1.81 (1=strong buy, 5=strong sell) and a strong-buy count of 7. These signals suggest a generally favorable view from the investment community.
Key takeaways
  • Wanhua Chemical Group has a moderate debt-to-equity ratio of 1.33, indicating a balanced capital structure.
  • The company's ROE of 4.39% and ROA of 1.37% suggest room for improvement in profitability.
  • Analysts have a generally positive outlook, with a mean price target of 98.52 CNY and a median of 105.00 CNY.
  • The company's liquidity position is medium, with a current ratio of 0.63.
  • Wanhua's capital expenditures of -20.07 billion CNY indicate ongoing investment or asset adjustments.
  • The company's revenue is concentrated in its core chemical products, with no detailed geographic breakdown provided.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$50.91B
Gross profit$7.55B
Operating income$5.20B
Net income$4.02B
R&D
SG&A
D&A
SBC
Operating cash flow$10.29B
CapEx-$20.07B
Free cash flow
Total assets$294.24B
Total liabilities$202.76B
Total equity$91.48B
Cash & equivalents
Long-term debt$121.26B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$145.54B$29.43B$24.65B$32.6M
FY-3$165.57B$19.84B$16.23B-$16.19B
FY-2$175.36B$20.39B$16.82B-$21.57B
FY-1$182.07B$17.97B$13.03B-$17.98B
FY0$203.23B$16.67B$12.53B-$5.11B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$190.31B$68.50B
FY-3$200.84B$76.84B
FY-2$253.04B$88.66B
FY-1$293.33B$94.63B
FY0$323.01B$108.31B
PeriodOCFCapExFCFSBC
FY-4$27.92B-$27.00B$32.6M
FY-3$36.34B-$32.66B-$16.19B
FY-2$26.80B-$43.10B-$21.57B
FY-1$30.05B-$35.83B-$17.98B
FY0$33.11B-$30.71B-$5.11B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$50.91B$5.20B$4.02B
FQ-6$50.54B$3.99B$2.92B
FQ-5$34.46B$3.41B$1.94B
FQ-4$43.07B$4.02B$3.08B
FQ-3$47.83B$3.63B$3.04B
FQ-2$53.32B$4.14B$3.03B
FQ-1$59.01B$4.88B$3.37B
FQ0$54.05B$5.30B$3.72B
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$294.24B$91.48B
FQ-6$309.64B$93.20B$41.19B
FQ-5$293.33B$94.63B
FQ-4$317.52B$98.31B$36.83B
FQ-3$315.96B$99.75B
FQ-2$328.32B$105.15B$35.92B
FQ-1$323.01B$108.31B
FQ0$347.67B$111.40B$46.83B
PeriodOCFCapExFCFSBC
FQ-7$10.29B-$20.07B
FQ-6$19.31B-$29.75B
FQ-5$30.05B-$35.83B
FQ-4$581.2M-$9.09B
FQ-3$10.53B-$17.03B
FQ-2$17.02B-$23.75B
FQ-1$33.11B-$30.71B
FQ0$6.86B-$5.03B
Valuation
Market price$77.58
Market cap$242.86B
Enterprise value$364.12B
P/E60.5
Reported non-GAAP P/E
EV/Revenue7.2
EV/Op income70.0
EV/OCF35.4
P/B2.6
P/Tangible book2.6
Tangible book$91.48B
Net cash-$121.26B
Current ratio0.6
Debt/Equity1.3
ROA1.4%
ROE4.4%
Cash conversion2.6%
CapEx/Revenue-39.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
Metric600309Activity
Op margin10.2%5.5% medp25 -0.0% · p75 10.8%above median
Net margin7.9%4.1% medp25 0.1% · p75 8.8%above median
Gross margin14.8%20.5% medp25 12.4% · p75 29.7%below median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-39.4%-6.2% medp25 -13.4% · p75 -2.6%bottom quartile
Debt / equity133.0%37.1% medp25 10.3% · p75 82.0%top quartile
Observations
IR observations
Mean price target98.52 CNY
Median price target105.00 CNY
High price target126.00 CNY
Low price target53.00 CNY
Mean recommendation1.81 (1=strong buy, 5=strong sell)
Strong-buy count7.00
Buy count7.00
Hold count1.00
Sell count0.00
Strong-sell count1.00
Mean EPS estimate5.52 CNY
Last actual EPS3.99 CNY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 06:17 UTC#959e169e
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 00:14 UTCJob: e83aa950